Top

Published in:

Open Access 01-09-2018 | Original Article

Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials

Authors: Gulinur Abdulrehman, Kaiyue Xv, Yuhua Li, Ling Kang

Published in: Lasers in Medical Science | Issue 7/2018

Abstract

The aim of this study is to investigate the antitumor effects and possible mechanisms of meta-tetrahydroxyphenylchlorin-mediated photodynamic therapy (m-THPC-PDT) on human primary (SW480) and metastatic (SW620) colon cancer cell lines. SW480 and SW620 cells were incubated with various concentrations of m-THPC, followed by photodynamic irradiation. Subcellular localization of m-THPC in cells was observed with confocal laser scanning microscopy (CLSM). Photocytotoxicity of m-THPC in the two cells was investigated by using MTT assay. The flow cytometry was employed to detect the cell apoptosis. The migration and long-term recovery ability were determined by scratch test and colony formation assay respectively. CLSM showed that m-THPC was mainly distributed within the endoplasmic reticulum (ER) and lysosome of SW480 cells and within the lysosome and mitochondria of SW620 cells. m-THPC-PDT induced a dose-dependent and light energy-dependent cytotoxicity in SW480 and SW620 cells. Apoptosis rate was approximately 65 and 25% in SW480 and SW620 respectively when the concentration of m-THPC increased to 11.76 μM. However, the rate of necrotic cells had no significant changes in two cell lines. The colony formation and migration ability of the two cell lines were decreased with m-THPC-PDT treatment in a dose-dependent manner. PDT with m-THPC not only could effectively inhibit cell proliferation and decrease migration ability and colony formation ability, but also could effectively kill SW480 and SW620 cells in a dose-dependent manner in vitro. These results suggest that m-THPC is a promising sensitizer that warrants further development and extensive studies towards clinical use of colorectal cancer.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed

Dai Z, Zheng RS, Zou XN, ZHand SW, Zeng HM, Li N, Chen WQ (2012) Analysis and prediction of colorectal cancer incidence trend in China. Zhonghua Yu Fang Yi Xue Za Zhi 46(7):598–603PubMed

Nitsche U, Maak M, Schuster T, Künzli B, Langer R, Slotta-Huspenina J, Janssen KP, Friess H, Rosenberg R (2011) Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg 254(5):793–800 discussion 800–801CrossRefPubMed

Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30CrossRefPubMed

Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21(20):3737–3743CrossRefPubMed

Benizri EI, Bernard JL, Rahili A, Benchimol D, Bereder JM (2012) Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 10:56CrossRefPubMedPubMedCentral

Serra A, Pineiro M, Pereira N, Gonsalves AR, Laranjo M, Abrantes M, Botelho F (2008) A look at clinical applications and developments of photodynamic therapy. Oncol Rev 2:235–249CrossRef

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61(4):250–281CrossRefPubMedPubMedCentral

Allison R, Moghissi K, Downie G, Dixon K (2011) Photodynamic therapy (PDT) for lung cancer. Photodiagn Photodyn Ther 8(3):231–239CrossRef

10.

Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR (2011) Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) 3(2):2516–2539CrossRef

11.

Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905CrossRefPubMedPubMedCentral

12.

Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3(5):380–387CrossRefPubMed

13.

Senge MO, Brandt JC (2011) Temoporfin (Foscan®, 5,10,15,20-tetra (m-hydroxyphenyl) chlorin)—a second-generation photosensitizer. Photochem Photobiol 87(6):1240–1296CrossRefPubMed

14.

Mitra S, Foster TH (2005) Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin. Photochem Photobiol 81(4):849–859CrossRefPubMed

15.

De Visscher SA, Dijkstra PU, Tan IB, Roodenburg JL, Witjes MJ (2013) mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review. Oral Oncol 49(3):192–210CrossRefPubMed

16.

Durbec M, Cosmidis A, Fuchsmann C, Ramade A, Céruse P (2013) Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx. Eur Arch Otorhinolaryngol 270(4):1433–1439CrossRefPubMed

17.

Wang JD, Shen J, Zhou XP, Shi WB, Yan JH, Luo FH, Quan ZW (2013) Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer. Lasers Med Sci 28(6):1541–1548CrossRefPubMed

18.

Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC, Mabry ND (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36(12):4562–4569PubMed

19.

Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y, Ding Y (2010) Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 59(9):1226–1235CrossRefPubMed

20.

Wei MF, Chen MW, Chen KC, Lou PJ, Lin SY, Hung SC, Hsiao M, Yao CJ, Shieh MJ (2014) Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy 10(7):1179–1192CrossRefPubMedPubMedCentral

21.

Frame FM, Savoie H, Bryden F, Giuntini F, Mann VM, Simms MS, Boyle RW, Maitland NJ (2015) Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis. Cancer Med, Nov 21. doi:https://doi.org/10.1002/cam4.553

22.

Allison RR, Moghissi K (2013) Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc 46(1):24–29CrossRefPubMedPubMedCentral

23.

Kohl E, Karrer S (2013) New developments in photodynamic therapy. Hautarzt 64(5):363–369CrossRefPubMed

24.

Wolfsen HC (2005) Carpe luz—seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. Gastrointest Endosc 62(4):499–503CrossRefPubMed

25.

Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244(2):230–239CrossRefPubMedPubMedCentral

26.

Yanai H, Kuroiwa Y, Shimizu N, Matsubara Y, Okamoto T, Hirano A, Nakamura Y, Okita K, Sekine T (2002) The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients. Int J Gastrointest Cancer 32(2–3):139–142CrossRefPubMed

27.

Nakamura T, Fukui H, Ishii Y, Ejiri K, Ejiri M (2003) Photodynamic therapy with polypectomy for rectal cancer. Gastrointest Endosc 57(2):266–269CrossRefPubMed

28.

Abulafi AM, Dejode M, Allardice JT, Ansell J, Rogers J, Williams NS (1995) Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer. Br J Surg 82(2):178–181CrossRefPubMed

29.

Jerjes W, Upile T, Betz CS, El Maaytah M, Abbas S, Wright A, Hopper C (2007) The application of photodynamic therapy in the head and neck. Dent Update 34(8):478–480, 483–484, 486

30.

Jerjes W, Upile T, Hamdoon Z, Nhembe F, Bhandari R, Mackay S, Shah P, Mosse CA, Brookes JA, Morley S, Hopper C (2009) Ultrasound-guided photodynamic therapy for deep seated pathologies: prospective study. Lasers Surg Med 41(9):612–621CrossRefPubMed

31.

Kawczyk-Krupka A, Bugaj AM, Latos W, Zaremba K, Wawrzyniec K, Sieroń A (2015) Photodynamic therapy in colorectal cancer treatment: the state of the art in clinical trials. Photodiagn Photodyn Ther 12(3):545–553CrossRef

32.

Marchal S, François A, Dumas D, Guillemin F, Bezdetnaya L (2007) Relationship between subcellular localisation of Foscan and caspase activation in photosensitised MCF-7 cells. Br J Cancer 96(6):944–951CrossRefPubMedPubMedCentral

33.

Teiten MH, Bezdetnaya L, Morlière P, Santus R, Guillemin F (2003) Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br J Cancer 88(1):146–152CrossRefPubMedPubMedCentral

34.

Guan J, Lai X, Wang X, Leung AW, Zhang H, Xu C (2014) Photodynamic action of methylene blue in osteosarcoma cells in vitro. Photodiagn Photodyn Ther 11(1):13–19CrossRef

35.

Sheng C, Pogue BW, Wang E, Hutchins JE, Hoopes PJ (2004) Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors. Photochem Photobiol 79(6):520–525CrossRefPubMed

36.

Henderson BW, Busch TM, Snyder JW (2006) Fluence rate as a modulator of PDT mechanisms. Lasers Surg Med 38(5):489–493CrossRefPubMed

37.

Aleksandra KK, Wojciech L, Magdalena L, Zenon PC, Aleksander S (2016) ALA-induced photodynamic effect on viability, apoptosis, and secretion of S100 protein, secreted by colon cancer cells in vitro. Photodiagn Photodyn Ther 15(2):218–227

38.

Mamoru T, Hiromi K, Motoshi M, Shiho S, Satoru T, Ryoto T, Haruo A, Hiromi O, Shigenobu Y, Akimichi M, Takashi J (2011) Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer. Anticancer Res 31(2):736–770

39.

Broekgaarden M, Weijer R, Van Gulik TM, Hamblin MR, Heger M (2015) Tumor cell survival pathways activated by photodynamic therapy: molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev 34(4):643–690CrossRefPubMedPubMedCentral

40.

Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776(1):86–107PubMed

41.

Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2011) DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochem Photobiol Sci 10(5):670–680CrossRefPubMed

42.

Coupienne I, Fettweis G, Rubio N, Agostinis P, Piette J (2011) 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma. Photochem Photobiol Sci 10(12):1868–1878CrossRefPubMed

43.

Broekgaarden M, de Kroon AI, Van Gulik TM, Heger M (2014) Development and in vitro proof-of-concept of interstitially targeted zinc-phthalocyanine liposomes for photodynamic therapy. Curr Med Chem 21(3):377–391CrossRefPubMed

44.

Andrzejak M, Price M, Kessel DH (2011) Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells. Autophagy 7(9):979–984CrossRefPubMedPubMedCentral

45.

Liu L, Zhang Z, Xing D (2011) Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage. Free Radic Biol Med 51(1):53–68CrossRefPubMed

46.

Wawrzyńska M, Kałas W, Biały D, Zioło E, Arkowski J, Mazurek W, Strzadała L (2010) In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells. Arch Immunol Ther Exp 58(1):67–75CrossRef

47.

Van Custem E, Oliverira J, ESME Guideliner Working Group (2009) Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Anm Oncol Suppl 4:61–63

Title: Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials
Authors: Gulinur Abdulrehman
Kaiyue Xv
Yuhua Li
Ling Kang
Publication date: 01-09-2018
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 7/2018
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-018-2524-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of meta-tetrahydroxyphenylchlorin photodynamic therapy on isogenic colorectal cancer SW480 and SW620 cells with different metastatic potentials

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2018

Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid

Evaluation of bone repair after application of a norbixin membrane scaffold with and without laser photobiomodulation (λ 780 nm)

Low-level laser irradiation modifies the effect of hyperglycemia on adhesion molecule levels

Indocyanine green-mediated photobiomodulation on human osteoblast cells

Fractional CO2 laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis

A novel Met-IR-782 near-infrared probe for fluorescent imaging-guided photothermal therapy in breast cancer